Results 31 to 40 of about 5,823,340 (161)

Children with Non-Neurogenic Lower Urinary Tract Dysfunction Require Less Frequent and Number of Botulinum Toxin Injections Than Neurogenic Ones

, 2022
Objective:To evaluate pediatric patients with lower urinary tract dysfunction (LUTD) who received bladder or external sphincter botulinum toxin A (BTX) injection in terms of effectiveness and permanence.Materials and Methods:We analyzed 80 patients ...
Erman Ceyhan, Ruslan Jafarov, Vasileios Tatanis, Serdar Tekgül, Ali Cansu Bozacı, Turan Mammadaliyev, Kamranbay Gasimov, Hasan Serkan Doğan   +7 more
core   +1 more source

Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital

Scandinavian Journal of Urology, 2022
Objective Sacral neuromodulation (SNM) is a well-established treatment modality for idiopathic overactive bladder and urgency incontinence, idiopathic fecal incontinence and non-obstructive urinary retention.
Hanne Kobberø, Margrethe Andersen, Karin Andersen, Torben Brøchner Pedersen, Mads Hvid Poulsen   +4 more
doaj   +1 more source

Efficacy of Tibial Nerve Stimulation in Neurogenic Lower Urinary Tract Dysfunction Among Patients with Multiple Sclerosis: A Systematic Review and Meta-analysis

Urology Research and Practice, 2023
Objective: This study was performed to systematically review the current literature on the effects of transcutaneous tibial nerve stimulation and percutaneous tibial nerve stimulation on multiple sclerosis-induced neurogenic lower urinary tract ...
Fateme Tahmasbi, Samaneh Hosseini, Sakineh Hajebrahimi, Reza Mosaddeghi Heris, Hanieh Salehi-Pourmehr   +4 more
doaj   +1 more source

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome [PDF]

, 2010
Objective: The aim of the study was a prospective assessment of patient-reported side effects in an open-label study after intradetrusor botulinum toxin injections for idiopathic overactive bladder (OAB). Patients and Methods: Botulinum toxin A injection
Mayer, Margit E., Yasmin Hocaoglu, Alexander Buchner, Hocaoglu, Yasmin, Buchner, Alexander, Christian G. Stief, Bauer, Ricarda M., Alexander Roosen, Stief, Christian G., May, Florian, Christian Gratzke, Ricarda M. Bauer, Margit E. Mayer, Gratzke, Christian, Florian May, Roosen, Alexander   +15 more
core   +1 more source

Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review [PDF]

, 2016
CONTEXT Transcutaneous electrical nerve stimulation (TENS) is a promising therapy for non-neurogenic lower urinary tract dysfunction and might also be a valuable option in patients with an underlying neurological disorder.
Pannek, Jürgen, Kessler, Thomas M, Phé, Véronique, Musco, Stefania, Hamid, Rizwan, Ecclestone, Hazel, Del Popolo, Giulio, Schneider, Marc P, Castro-Diaz, David, Padilla Fernández, Bárbara, Bachmann, Lucas M, Groen, Jan, Gross, Tobias, Blok, Bertil F M, Hoen, Lisette A 't, Karsenty, Gilles   +15 more
core   +1 more source

Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction [PDF]

, 2014
BACKGROUND Sacral neuromodulation has become a well-established and widely accepted treatment for refractory non-neurogenic lower urinary tract dysfunction, but its value in patients with a neurological cause is unclear.
Bernhard Kiss, Elena Miramontes, Pannek, Jürgen, Kiss, Bernhard, Miramontes, Elena, Jens Wöllner, Alfons G Kessels, Knüpfer, Stephanie C, Bachmann, Lucas M, Abt, Dominik, Livio Mordasini, Liechti, Martina D, Burkhard, Fiona C., Mordasini, Livio, Fiona C Burkhard, Burkhard, Fiona C, Engeler, Daniel S, Marc P Schneider, Wöllner, Jens, Kessler, Thomas M, Mordasini, Livio Marco, Kessler, Thomas M., Schneider, Marc P, Thomas M Kessler, Lucas M Bachmann, Stephanie C Knüpfer, Daniel S Engeler, Kessels, Alfons G, Martina D Liechti, Jürgen Pannek, Dominik Abt   +30 more
core   +3 more sources

Early warning model construction and validation for urinary tract infection in patients with neurogenic lower urinary tract dysfunction (NLUTD): a retrospective study [PDF]

PeerJ, 2022
Background This study was performed to construct and validate an early risk warning model of urinary tract infection in patients with neurogenic lower urinary tract dysfunction (NLUTD).
Liqiong Zhou, Surui Liang, Qin Shuai, Chunhua Fan, Linghong Gao, Wenzhi Cai   +5 more
doaj   +2 more sources

Neurogenic mechanisms in bladder and bowel ageing [PDF]

, 2015
The prevalence of both urinary and faecal incontinence, and also chronic constipation, increases with ageing and these conditions have a major impact on the quality of life of the elderly.
Saffrey, Jill, Saffrey, M. Jill, Ranson, Richard N., Ranson, Richard, M. Jill Saffrey, Richard N. Ranson   +5 more
core   +1 more source

Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients

Brain Sciences, 2021
Background: The aim of this study was to perform a cross-sectional study of Polish neurogenic patients to measure, at the population level, the prevalence, bother and behavior associated with treatment for lower urinary tract symptoms (LUTS) and ...
Mikolaj Przydacz, Marcin Chlosta, Tomasz Golabek, Piotr Chlosta   +3 more
doaj   +1 more source

Botulinum toxin-A for the treatment of overactive bladder: UK contributions [PDF]

, 2013
Background: Botulinum toxin-A (BoNT/A) is now established second-line management for refractory overactivebladder (OAB) and recognised in many incontinence guidelines and pathways.
Fowler, CJ, Panicker, J. N., Fowler, C. J., Dowson, C, Khan, MS, Seth, JH, Dasgupta, P, Dasgupta, P., Panicker, JN, Sahai, A, Dowson, C., Seth, J. H., Khan, M. S., Sahai, Arun   +13 more
core   +1 more source